What is the prevalence of Myelodysplastic Syndromes?
How many people do Myelodysplastic Syndromes affect? Do they have the same prevalence in men and women? And in the different countries?
The prevalence of Myelodysplastic Syndromes (MDS) varies depending on the population studied and the diagnostic criteria used. However, it is estimated that MDS affects approximately 3 to 4 per 100,000 individuals worldwide. The incidence of MDS increases with age, with the majority of cases occurring in individuals over 60 years old. MDS is more common in males than females. It is important to note that these figures may vary and should be interpreted in the context of specific populations and studies.
Myelodysplastic Syndromes (MDS) are a group of bone marrow disorders characterized by ineffective production of blood cells. The prevalence of MDS varies depending on several factors, including age, gender, and geographic location.
According to various studies, the overall prevalence of MDS ranges from 3 to 12 cases per 100,000 individuals. However, it is important to note that MDS primarily affects older adults, with the incidence increasing significantly with age. The prevalence among individuals aged 70 years or older is estimated to be 30 to 50 cases per 100,000 individuals.
MDS is slightly more common in males than females, with a male-to-female ratio of approximately 1.3:1. Additionally, the prevalence of MDS may vary across different regions, with higher rates reported in certain countries.
Early diagnosis and appropriate management of MDS are crucial for improving patient outcomes. If you suspect you or someone you know may have MDS, it is important to consult a healthcare professional for proper evaluation and guidance.
